Search
Tools for public health
Repository of policy and practice resources - substances of human origin
Repository of resources produced by national public health institutes, national ministries of health, or recognised and respected learned societies or academies.
Scientific and technical publications
Variant Creutzfeldt-Jacob disease in donors of blood and plasma having temporarily resided in or visited the United Kingdom
Since the risk assessment published by ECDC in August 2021 on the risk of vCJD disease transmission via blood and PDMP manufactured from donations obtained in the UK, no new cases of vCJD associated with dietary exposure or transfusion of blood or blood components have been reported in EU/EEA or in the rest of the world.
Scientific and technical publications
The EHA Research Roadmap: Transfusion Medicine
Stanworth, S.J., Brand, A., Kaveri, S.V., Vrielink, H., Greinacher, A., Domanović, D., von Lindern, M., Allard, S., Bayry, J., Bohonek, M., Buser, A., Claas, F.H.J., Knutson, F., Lozano, M., Olsson, M.L., Pirenne, F., Rebulla, P., So-Osman, C., Tissot, J.D., Toye, A.M., Ushiro-Lumb, I., van den Akker, E., Zeerleder, S.
Scientific and technical publications
The EHA Research Roadmap: Transfusion Medicine
Stanworth S.J., Brand A., Kaveri S.V., Vrielink H., Greinacher A., Domanović D., von Lindern M., Allard S., Bayry J., Bohonek M., Buser A., Claas F.H.J., Knutson F., Lozano M., Olsson M.L., Pirenne F., Rebulla P., So-Osman C., Tissot J.-D., Toye A.M., Ushiro-Lumb I., van den Akker E., Zeerleder S.
Scientific and technical publications
Risk assessment: The risk of variant Creutzfeldt-Jakob disease transmission via blood and plasma-derived medicinal products manufactured from donations obtained in the United Kingdom
ECDC assessed the risk to the EU/EEA of the presence and the possible transmission of prions, which have been linked to Creutzfeldt-Jakob disease, by blood and plasma-derived medicinal products (PDMPs) manufactured from donations obtained in the UK.
Scientific and technical publications
Suspected adverse reactions to COVID-19 vaccination and the safety of substances of human origin
The purpose of this document is to address the safety of donors and products involving Substances of Human Origin (SoHO) and the potential risk of thrombosis with thrombocytopenia adverse events following COVID-19 vaccination of a donor.
Scientific and technical publications
Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA - Second update
The documents in this page may have outdated information and recommendations could no longer apply. An update is currently underway.
News
West Nile fever monitoring: First cases reported in EU for 2018 season
In the past week, the first human cases of West Nile fever have been reported in the EU for the current transmission season.
Scientific and technical publications
Laboratory testing of non-partner sperm donors
The European Centre for Disease Prevention and Control was asked by the European Commission to assess the risk involved in changing the testing requirements for HIV (human immunodeficiency virus), hepatitis B virus (HBV), and hepatitis C virus (HCV) with regard to the quality and safety of non-partner semen donations.
Scientific and technical publications
Zika virus and safety of substances of human origin: a guide for preparedness activities in Europe – first update
This first update of the original guide was prompted by the evolution of the Zika virus epidemic, a new classification system for countries/areas, and recent scientific developments.